Depression or Substance Use? How Co-Occurring Diagnoses Are Made in Residential Treatment, the One-Month Guideline, and What to Tell Admissions

, ,
Treatment for High Functioning Depression

Many people arrive at residential treatment carrying two questions at once: “Is my drinking or drug use the problem?” and “Or is it depression, anxiety, or something else underneath?” Families ask the same thing at admission, often hoping for a clear answer on day one. In practice, a responsible program usually cannot give a final psychiatric diagnosis that early, and the reason is clinical, not bureaucratic. This post explains how co-occurring mental health conditions are evaluated during residential treatment, why the timing matters, and what to tell admissions so the evaluation starts on the right footing.

Why a Psychiatric Diagnosis Often Waits Until After Withdrawal

Alcohol, stimulants, opioids, cannabis and sedatives all change mood, sleep, appetite and concentration, both during heavy use and during withdrawal. Someone coming off methamphetamine can look severely depressed for days. Someone in early alcohol withdrawal can look like they have a panic disorder. Those symptoms are real and they are treated, but they do not yet tell a clinician whether an independent depressive or anxiety disorder exists.

When a diagnosis of depression can be separated from substance use: Under the DSM-5 diagnostic criteria, a depressive episode that starts during intoxication or withdrawal is generally classed as substance-induced, and clinicians look for symptoms that persist for a substantial period, about one month, after acute withdrawal or heavy intoxication ends before treating it as an independent disorder. A documented history of depression during earlier periods of sobriety also counts as evidence of an independent condition. That is why a residential program will usually describe early mood symptoms as provisional and revisit the diagnosis after the first few weeks of abstinence.

The paragraph above is the single most useful thing for families to understand. “We are watching it” in week one is not avoidance; it is how the diagnostic criteria are designed to work.

What Week One Actually Looks Like

The first week of residential care is usually dominated by sleep and physical stabilization. It is common for mood to dip partway through that first week, when the immediate relief of being in a safe place has worn off and the body is still recalibrating. Families who call during that window sometimes hear a loved one say “this isn’t working” or “I think I’ve always been depressed.” Both statements deserve to be taken seriously and passed on to staff, and both are common at that point in care.

By the second and third weeks, the picture often shifts. Sleep starts to regulate, appetite returns, and the person can engage in therapy groups with more focus. This is when clinicians get a clearer read on what is left once the substance effects have faded. For some people, the depression lifts substantially. For others, it stays put, and that persistence is itself diagnostic information.

Common Reasons Mood Symptoms Persist in Early Recovery

When low mood or anxiety continues past early withdrawal, clinicians typically consider several possibilities:

  • Independent depressive or anxiety disorder: A condition that existed before or alongside substance use and needs its own treatment plan.
  • Protracted withdrawal symptoms: Some people experience lingering sleep disturbance, irritability and low mood for weeks after stopping alcohol, opioids or benzodiazepines.
  • Trauma-related symptoms: Substance use sometimes masks post-traumatic stress symptoms that surface once the person is sober.
  • Grief and consequences: Lost relationships, legal problems and financial damage produce real sadness that is not always a disorder.
  • Medication effects or gaps: Psychiatric medications that were taken inconsistently during active use may need to be reassessed.

The National Institute on Drug Abuse (NIDA) describes substance use disorders and other mental illnesses as frequently occurring together and recommends that both be assessed and treated in an integrated way rather than one after the other. The National Institute of Mental Health (NIMH) makes a similar point about shared risk factors.

What Families Usually Notice First

Families often have the most valuable information in the room. They remember whether a loved one seemed withdrawn as a teenager before any drinking started, whether panic attacks came first or later, and whether there were long stretches of sobriety that were still hard emotionally. That timeline is exactly what a clinician needs to separate substance-induced symptoms from an independent disorder. Before the intake or family session, it helps to write down approximate dates rather than relying on memory in the moment.

Psychiatric Medications at Admission: What Happens to Them

People entering treatment are sometimes afraid that their antidepressant or other psychiatric medication will be stopped. In general, medications that were prescribed and taken as directed are reviewed by the medical team and continued unless there is a clinical reason to change them. Do not stop an antidepressant, mood stabilizer or antipsychotic on your own before admission; abrupt discontinuation of some of these medications can cause significant withdrawal effects or a return of symptoms.

Benzodiazepines are a separate case. Stopping benzodiazepines suddenly, like stopping alcohol after heavy daily use, can cause seizures and can be life-threatening. Withdrawal from either must be medically supervised. Tell admissions the exact dose and how long you have been taking it so the medical team can plan a safe taper.

What to Tell Admissions Before You Arrive

Here is a step you can take today: before your admissions call, write down and bring the following, ideally on one page:

  1. Every current medication: Name, dose, prescriber and the date you last took it, including anything taken irregularly.
  2. Past diagnoses: Any mental health diagnosis you have been given, by whom, and roughly when.
  3. Sober-period history: Whether depression, anxiety or panic were present during any stretch of 30 days or more without alcohol or drugs.
  4. Past hospitalizations or crisis care: Including any psychiatric holds or emergency visits.
  5. Current safety concerns: Any recent thoughts of suicide or self-harm, even if they have passed.

Then ask admissions three specific questions: “Who on your team does the psychiatric evaluation, and when in the stay does it happen?” “How often is the diagnosis revisited after withdrawal?” and “How will mental health care continue after discharge?” A program that offers integrated mental health treatment should be able to answer all three without hesitation.

If you would like to talk this through before admission, call our team at (877) 328-1968.

How Co-Occurring Care Fits Into Residential Treatment

In residential treatment, integrated care usually means the same team is watching both the substance use and the mental health picture day to day. Therapy groups address cravings and relapse prevention alongside mood regulation, sleep, and anxiety skills. Individual sessions give room to work on trauma or grief once the person is stable enough. The psychiatric provider adjusts medications based on how symptoms evolve rather than on a single snapshot from intake.

Insurance coverage for co-occurring care varies by plan. If cost is a concern, you can verify your insurance benefits before admission so there are no surprises about psychiatric services.

After Discharge: Keeping the Diagnosis Accurate

A diagnosis made in residential treatment is a working diagnosis. It should travel with the person to their outpatient therapist and prescriber, who can confirm or revise it as sobriety continues. Ask for a written summary of the psychiatric evaluation and current medications at discharge, and bring it to the first outpatient appointment. The SAMHSA National Helpline can help locate continuing care if you are moving to a different area.

When Symptoms Are an Emergency

If you or someone you love is thinking about suicide or is in immediate danger, call or text 988 to reach the 988 Suicide and Crisis Lifeline, or call 911. Do not wait for an admissions appointment.

For questions about residential treatment for co-occurring substance use and mental health conditions in Northern California, call Bodhi Addiction Treatment at (877) 328-1968.

This article is for educational purposes only and is not a substitute for professional medical or psychiatric advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your specific situation. Never stop or change a prescribed medication without medical guidance.

/by

When a Loved One Refuses Treatment in California: 5150 Holds, SB 43, and What Families Can Do

, ,
Pexels Tara Winstead 8383491 — Bodhi Addiction Treatment & Wellness

The call usually comes late in the evening. A parent or spouse has watched someone they love decline for months, has asked them to get help more times than they can count, and has just heard the same answer again: no. What they want to know next is practical. Can anyone make this person go to treatment in California? Who decides, how long does it last, and what happens afterward?

This guide walks through the legal tools that exist in California, what each one actually does, and what families can do today when a loved one refuses residential treatment. It is written from the admissions and intervention side of this work, where we see what happens after a hold ends, not just how it begins.

The Short Answer: What California Law Allows

In California, an adult who refuses substance use treatment generally cannot be placed in a residential addiction program against their will. Residential treatment is voluntary: the person has to consent to admission. What California law does allow is a 5150 hold under the Welfare and Institutions Code, which lets a peace officer or a county-designated professional detain a person for up to 72 hours of psychiatric evaluation and crisis care if they are a danger to themselves or others, or gravely disabled. Since Senate Bill 43, grave disability can now be based on a severe substance use disorder alone, and every county has been required to apply that expanded definition since January 1, 2026. A hold is an evaluation, not a treatment placement, so families should plan for what happens when the 72 hours end.

The Legal Tools, Step by Step

5150 hold (up to 72 hours): An involuntary hold for evaluation and crisis intervention at a designated facility, started by law enforcement or a county-designated clinician, not by a family member directly.

5250 certification (up to 14 days): If the facility believes the person still meets criteria at the end of the hold, it can certify them for intensive treatment, which triggers a certification review hearing.

LPS conservatorship: A court process, usually initiated by the county, for people who remain gravely disabled. It is a serious legal step that removes significant decision-making rights, and it is reserved for the most severe situations.

CARE Court: California’s CARE Act process, statewide since December 2024, is limited to people with schizophrenia spectrum or other psychotic disorders. A substance use disorder by itself does not qualify, which surprises many families who have read about it in the news.

None of these is a referral to a rehab program. Each is a crisis or court process run by county behavioral health and the hospital system.

What SB 43 Changed, and What It Did Not

SB 43 was signed in 2023 and took effect on January 1, 2024, with counties allowed to delay implementation until January 1, 2026. It made two changes that matter to families. First, it allows grave disability to be based on a severe substance use disorder, or a substance use disorder occurring alongside a mental health condition. Second, it broadened the definition so that a person can be found gravely disabled if they cannot provide for their own personal safety or necessary medical care, not only food, clothing, and shelter.

What SB 43 did not do is create a pathway from a hold into a residential addiction program. The law widened who can be evaluated. It did not change the fact that a residential program needs the person’s agreement to admit them, or the reality that local inpatient psychiatric and detox capacity is limited.

Why a Hold Often Ends Without Treatment

Families are sometimes told that a 5150 will “get them into rehab.” In practice, there are several reasons it often does not.

Evaluation, not placement: The hold exists to stabilize and assess a crisis, and once acute intoxication or withdrawal resolves, the person may no longer meet the legal criteria.

The clock runs on the facility’s schedule: Release can happen at any hour once the person no longer meets criteria, sometimes before family has been told.

Confidentiality limits what you hear: Without written consent from the patient, staff may not be able to confirm that your loved one is there at all.

No bed is being held: Unless someone has already lined up a voluntary program and verified insurance, there is nowhere ready to go at discharge.

The inconvenient truth we see from the admissions side is that the most useful window is often the hours right after a hold ends, when the person is sober, frightened, and briefly open to a different answer. Families who have already done the paperwork for a program are the ones who can act in that window.

What You Can Do Today

If there is immediate danger, call 911. For a mental health or substance use crisis that is not a medical emergency, call or text 988, the Suicide and Crisis Lifeline, which can connect you to local mobile crisis services. Short of a crisis, these are concrete steps a family can take this week:

  1. Write a one-page fact sheet now. List the substances used, roughly how much each day, the date and time of last known use, current prescriptions, medical conditions, and any statements about self-harm. Hand a copy to responding officers, crisis workers, or ER staff. Specific facts help clinicians decide whether criteria are met.
  2. Flag alcohol and benzodiazepine use clearly. Withdrawal from alcohol or benzodiazepines can cause seizures and can be life-threatening. It requires medical supervision. If your loved one drinks daily or takes benzodiazepines, say so first, in writing, to anyone treating them.
  3. Call your county behavioral health access line and ask two questions: “Who in this county can initiate a 5150 evaluation, and is there a mobile crisis team?” and “Who handles conservatorship investigations if someone is repeatedly gravely disabled?”
  4. Line up the voluntary option before you need it. Verify insurance benefits for residential treatment now, so a bed can be discussed the same day your loved one says yes. Our admissions team can talk this through at (877) 328-1968.

SAMHSA’s National Helpline at 1-800-662-4357 is free, confidential, and available 24 hours a day, 365 days a year for treatment referrals and information.

When Legal Tools Do Not Fit: Structured Intervention

Most families are not facing a situation that meets the legal criteria for a hold. Their loved one is still working, still functioning in some ways, and still saying no. For these families, the more realistic path is a planned conversation with clear boundaries, often guided by a trained interventionist.

A structured intervention is not an ambush. It works best when the family has agreed in advance on what they will say, what they will stop doing, and which program is ready to admit the person that day. A professional addiction interventionist can help a family plan that conversation, prepare for refusal, and avoid the common mistake of issuing consequences no one intends to keep.

The research on addiction treatment supports persistence. The National Institute on Drug Abuse describes addiction as a treatable condition and notes that treatment does not need to be voluntary at the outset to be effective; outside pressure from family, employers, or the legal system can help a person engage. That does not mean pressure works every time. It means a “no” today is not the final answer.

Taking Care of Yourself While You Wait

Family members often carry this alone for a long time. Support groups for families, individual counseling, and education about substance use disorders can reduce isolation and help you hold boundaries without giving up on the relationship. SAMHSA’s help and referral resources are a reasonable place to start, and the National Institute on Alcohol Abuse and Alcoholism offers plain-language guidance if alcohol is the primary concern.

Talk to Someone Who Does This Every Day

If your loved one is refusing treatment and you are not sure which of these options fits, a confidential conversation can help you sort out what is a crisis, what is a planning problem, and what can be done this week. Bodhi Addiction Treatment provides residential drug and alcohol treatment in Northern California, and our team can walk you through admissions, insurance, and intervention options. Call (877) 328-1968.

This article is for educational purposes only and is not legal or medical advice. Laws and county procedures change, and how they apply depends on the specific facts. Consult an attorney or your county behavioral health department about legal options, and a qualified clinician about medical care. If someone is in immediate danger, call 911. For a mental health or substance use crisis, call or text 988.

/by

Bringing Your Prescriptions to Residential Treatment: Medication Reconciliation, Controlled Medications, and What to Tell Admissions

, ,
Mental Health Treatment | Bodhi Addiction & Wellness

Most people calling about residential treatment ask about insurance, length of stay and what to pack. Far fewer ask the question that most often causes a problem on admission day: what happens to the medications I already take? Blood pressure pills, an antidepressant, an inhaler, a stimulant for ADHD, a sleep aid, a benzodiazepine prescribed years ago. Every one of them has to be accounted for before the first night, and the process that does it has a name: medication reconciliation.

This guide explains how that process works in a residential setting, why controlled prescriptions are handled differently, and exactly what to have ready before you call admissions.

What Medication Reconciliation Means in Residential Treatment

Medication reconciliation in residential addiction treatment is the process of comparing every medication a person reports taking, including prescriptions, over-the-counter products and supplements, against pharmacy records and prescriber information, so the medical team can decide on the first day which medications continue unchanged, which are adjusted, which are tapered under supervision, and which are paused. It is completed at intake and repeated at discharge, and it depends heavily on how complete and accurate the list the person brings with them is.

In practice, the medical team is answering four questions for each item: Is it actually prescribed to this person? Is it being taken as prescribed? Does it interact with withdrawal management or with medications for addiction treatment? And is stopping it suddenly safe?

Why Controlled Prescriptions Get a Closer Look

Most routine medications, such as those for blood pressure, thyroid, diabetes or asthma, simply continue. The closer review is reserved for medications that can cause dependence or that change how withdrawal behaves.

Benzodiazepines: stopping them abruptly after regular use can cause seizures, so any change must be a supervised taper, never a sudden stop.

Opioid pain medications: combined with benzodiazepines or alcohol they raise the risk of dangerously slowed breathing, which affects how both are managed.

Stimulants prescribed for ADHD: the team weighs the documented diagnosis against current substance use before deciding whether to continue, adjust or pause.

Sleep medications and sedating supplements: these can stack with withdrawal medications and with each other, so the full list matters, including products bought without a prescription.

The U.S. Food and Drug Administration (FDA) has addressed the risks of benzodiazepine and opioid prescriptions directly. In August 2016 it required boxed warnings, its most prominent safety label, on opioid and benzodiazepine products about the dangers of using them together. In September 2020 it required the boxed warning on all benzodiazepines to be updated to describe the risks of misuse, addiction, physical dependence and withdrawal reactions. Those two dated label changes are a large part of why residential addiction treatment programs handle these prescriptions with extra care rather than continuing them automatically. The National Institute on Drug Abuse (NIDA) also publishes plain-language information on prescription medication misuse that families may find useful.

A Safety Point That Overrides Everything Else

If you or your loved one drinks heavily every day, or takes a benzodiazepine daily, do not stop on your own in the days before admission to “get a head start.” Withdrawal from alcohol and from benzodiazepines can cause seizures and, in severe cases, can be life-threatening. Medical supervision is required. The safest plan is usually to continue as you are, report your use honestly, and let the medical team manage the transition. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) describes alcohol withdrawal as a condition that can require medical treatment, and the American Society of Addiction Medicine (ASAM) publishes clinical guidelines for managing it.

If you are unsure whether it is safe to wait until admission, call us at (877) 328-1968 and ask to speak with someone about it before you change anything.

What We See Go Wrong on Admission Day

From years of admissions work in Northern California, the medication problems we see are rarely dramatic. They are logistical, and almost all of them are preventable:

  • Pills in a pill organizer or a plastic bag. Medications that are not in the original pharmacy-labeled container usually cannot be identified and verified, so they cannot be given until a replacement is obtained. That can mean a delay of a day or more for a medication the person depends on.
  • A list from memory. People commonly forget the inhaler, the eye drops, the once-weekly injection, or the supplement they take every night. Each omission is a gap in the medical picture.
  • Prescriptions from several prescribers. When a primary care doctor, a psychiatrist and a pain specialist each prescribe something, no single office has the whole list. The treatment team may be the first to see it all together.
  • Underreporting use. Saying “two drinks a night” when it is closer to a bottle, or “as prescribed” when it is twice the dose, does not change what the body will do in withdrawal. It only means the plan is built on the wrong numbers.

None of these reflect badly on the person. They are what happens when someone is preparing for treatment under stress. They are also easy to fix in advance.

What to Do Before You Call Admissions

Here is a short checklist you can complete today, before the admissions call or before admission day:

  1. Gather every bottle. Put every prescription, over-the-counter medication and supplement you have taken in the last 30 days on one table, in its original labeled container.
  2. Write one list. For each item, write the name, the dose, how often you actually take it, the prescriber, and the pharmacy. “Actually” matters more than “supposed to.”
  3. Call your pharmacy. Ask for a printed medication history. Most pharmacies can provide one, and it often catches items people forget.
  4. Flag the controlled ones. Circle anything that is a benzodiazepine, an opioid, a stimulant or a sleep medication, and note how long you have taken it.
  5. Ask these three questions on the admissions call: “Which of my medications will continue on day one?” “If a medication needs to be tapered, who sets the schedule?” “If something I take is not continued, will my prescriber be told?”

Bring the list, the bottles and the pharmacy printout on admission day. Admissions can tell you about any program-specific rules, such as how medications are stored and dispensed. You can start that conversation at (877) 328-1968.

What Happens After Intake

Once the medical team has the list, decisions are typically made in the first hours or day. Continued medications are usually stored and dispensed by staff rather than kept by the person. Medications that are tapered follow a written schedule. If a medication for addiction treatment, such as buprenorphine or naltrexone, is part of the plan, it is checked against everything else on the list first.

Reconciliation happens again at discharge. That second pass is just as important: the person should leave with a single, current list, a clear note on anything that was changed and why, and confirmation that the outpatient prescriber has been informed. If you are planning the step after residential care, our pages on partial hospitalization and outpatient treatment explain how care typically continues. You can also read about our approach to residential treatment.

For Families Helping With Preparation

Families often end up doing the practical work: collecting bottles from the bathroom cabinet, calling the pharmacy, finding the psychiatrist’s phone number. That help is valuable. It works best when the person entering treatment is part of it, because only they know what they actually take and how often. If your loved one is reluctant to share details with you, encourage them to share them directly with admissions instead. The goal is an accurate list, not who compiles it.

For confidential, free help finding treatment and support at any hour, the SAMHSA National Helpline is available 24 hours a day, 365 days a year, at 1-800-662-4357. If you or someone you love is in crisis or thinking about suicide, call or text 988. In an emergency, call 911.

Talk to Bodhi Before You Change Anything

If you are preparing for residential treatment and are unsure what to do with a current prescription, the most useful step is a conversation before admission, not on the day. Call Bodhi Addiction Treatment at (877) 328-1968 to talk through your medications, your use and what to bring.

This article is for educational purposes only and is not medical advice. Do not start, stop or change any medication without guidance from a qualified healthcare provider. Withdrawal from alcohol or benzodiazepines can be dangerous and requires medical supervision.

/by

Leaving Residential Treatment Against Medical Advice: What Happens, the First 24 Hours, and What to Ask For Before You Go

, ,
Capitola Beach — Bodhi Addiction Treatment & Wellness

Most people who think about leaving residential treatment early do it in the first week, often between day three and day seven. Withdrawal is easing, sleep is still broken, the novelty has worn off, and a voice says, “I’m fine now. I can do the rest at home.” Families get the phone call that starts with “Come pick me up.”

This guide explains what actually happens when someone leaves residential treatment against medical advice (AMA), why the first 24 hours afterward carry real medical risk, and the specific things to ask for before walking out the door. It is written from the admissions and clinical side of residential care in Northern California, where these conversations happen every week.

What “Against Medical Advice” Means in Residential Treatment

Leaving against medical advice means a person ends their stay before the treatment team recommends discharge. For an adult who admitted voluntarily, residential treatment is not a locked setting, and the program generally cannot hold someone who chooses to leave. What staff can do is slow the moment down, make sure the person is medically safe to go, and send them out with a plan instead of nothing.

In practice, an AMA discharge usually involves a conversation with a counselor or clinical lead, a check with medical staff about current withdrawal status and medications, and a form acknowledging that discharge is against the team’s recommendation. Signing that form does not erase the person’s record or bar them from coming back. It documents that the risks were explained.

Why People Leave Early: The Common Triggers

The reasons people give for leaving are usually not the real reasons. In residential work, the same handful of pressures show up again and again:

  • Post-acute withdrawal discomfort: Poor sleep, irritability, and low mood can linger for days or weeks after acute withdrawal ends, and they feel like proof that treatment “isn’t working.”
  • Cravings that peak without warning: A craving can arrive as a sudden, urgent certainty that leaving is the only reasonable choice, then fade within hours if the person stays put.
  • Outside pressure: A partner, employer, landlord, or court date creates a deadline that feels more pressing than the remaining days of care.
  • Conflict on the unit: A disagreement with a peer or staff member turns into “this place isn’t right for me.”
  • Feeling better too fast: Once the fog lifts, it is easy to mistake physical stabilization for recovery and conclude the job is done.

Naming the trigger matters, because most of them have a fix that does not require leaving: a medication adjustment, a room change, a call with the employer, a family session.

The Medical Risks in the First 24 Hours After Leaving

Leaving early is not only a setback in progress. Depending on the substance, it can be physically dangerous.

Alcohol and benzodiazepines: If someone leaves while still in withdrawal from alcohol or partway through a benzodiazepine taper, they can develop seizures and other serious complications. Withdrawal from either should only happen under medical supervision. Stopping a taper abruptly, or drinking to “take the edge off” after leaving, can make things worse. If a person who has left shows confusion, shaking, hallucinations, or a seizure, call 911.

Opioids and lost tolerance: After even a short period without opioids, tolerance drops. Returning to a previous amount, especially in a drug supply that may contain fentanyl, can cause an overdose. According to the National Institute on Drug Abuse (NIDA), naloxone can rapidly reverse an opioid overdose and quickly restore normal breathing, and it is available as a prepackaged nasal spray that requires no assembly.

Interrupted medications: People leaving mid-stay may be partway through starting buprenorphine, a psychiatric medication, or a medication for alcohol use disorder. Leaving without a prescription or a follow-up appointment can create a gap at the worst possible time.

Before You Walk Out: Five Things to Ask For Today

If you or someone you love has decided to leave residential treatment early, these five requests take less than an hour and can be the difference between a rough week and an emergency. Ask the staff, in this order:

  1. A medical check before you go. Ask the nurse or medical provider, “Am I medically safe to leave today, and what symptoms should send me to the ER?” Write the answer down.
  2. Your current medication list and prescriptions. Ask for printed copies of every medication, dose, and the next scheduled dose, plus prescriptions or a bridge supply where appropriate.
  3. Naloxone, if opioids are part of the history. Ask for a naloxone kit to take home, and make sure someone in the household knows where it is kept.
  4. A next appointment, not a phone number. Ask staff to book a specific date and time with an outpatient provider, a partial hospitalization program, or an outpatient program before you leave the building.
  5. The readmission question. Ask directly, “If I change my mind in a day or a week, what is the process to come back?” Knowing the door is open makes it easier to walk back through it.

A practical step for families: if your loved one calls asking to be picked up, ask them to wait 30 minutes and talk to their counselor first, then call the program yourself. Many urges to leave pass in that window.

What Families Can Do When the “Come Get Me” Call Comes

That phone call is hard. You want your loved one to be comfortable, and you also know what happened the last time they came home early. A few things help:

  • Stay calm and ask what happened today, rather than arguing about leaving.
  • Tell them you love them and that you support them finishing treatment.
  • Ask whether they have talked with their counselor or the medical team yet.
  • If they leave anyway, focus on safety: naloxone in the house, a follow-up appointment on the calendar, and a clear plan for what you will do if symptoms of withdrawal or overdose appear.

Families can also call our admissions team for guidance on how to handle the conversation, even if the person is in treatment somewhere else. Reach us at (877) 328-1968.

Free Help Is Available at Any Hour

Leaving residential treatment early does not end the option of getting help. SAMHSA’s National Helpline, 1-800-662-HELP (4357), is a free, confidential treatment referral and information service that operates 24 hours a day, 365 days a year, in English and Spanish, for individuals and families facing mental health or substance use disorders, according to the Substance Abuse and Mental Health Services Administration (SAMHSA). If someone has left treatment and is struggling at 2 a.m., that line is answered.

If someone is in immediate danger or is having thoughts of suicide, call or text 988 or call 911.

Leaving Is Not the End of the Story

An AMA discharge is common, and it is not a moral failure. Many people who leave early come back, sometimes within days, and do well the second time because they understand what they are walking into. What matters most is that the person leaves with a medical check, their medications, naloxone where relevant, and a real appointment, and that everyone knows how to come back.

If you are weighing whether to leave treatment, or trying to help someone who already has, talk to us first. Call (877) 328-1968 to speak with our admissions team about next steps, readmission, or a lower level of care that fits where you are now.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can cause seizures and requires medical supervision. Always talk with a qualified healthcare provider about your specific situation. If you are experiencing a medical emergency, call 911.

/by

Nicotine in Residential Treatment: Smoking Policies, the Seven FDA-Approved Quit Medications, and What to Ask Admissions

, ,
Peaceful natural setting representing mindfulness practice in addiction recovery

Almost every admissions call eventually gets to the same question, usually asked a little sheepishly: “Can I smoke there?” or “Can I bring my vape?” It sounds like a small logistics detail next to detox and insurance. In practice, nicotine shapes the first week of residential treatment more than most people expect, and a plan for it, made before admission day, removes one of the most common reasons people feel like leaving early.

This guide covers how nicotine is usually handled in residential drug and alcohol treatment, which medications exist, how nicotine withdrawal overlaps with other withdrawal, and the specific questions to ask admissions before you arrive.

Why Nicotine Belongs in the Treatment Plan

Tobacco and nicotine use are far more common among people with substance use disorders than in the general population, a pattern documented by the National Institute on Drug Abuse (NIDA). For a long time, many programs treated cigarettes as the one habit to leave alone during recovery, on the theory that quitting everything at once was too much. That view has shifted. Federal guidance from SAMHSA encourages behavioral health programs to address tobacco as part of care rather than set it aside, and research summarized by NIDA generally suggests that working on nicotine during addiction treatment does not undermine recovery from other substances and may support it.

That does not mean anyone is required to quit nicotine the day they walk in. It means nicotine is a clinical question that deserves an answer in the admission plan, the same way sleep, medications, and withdrawal do.

The Seven FDA-Approved Quit Medications

The U.S. Food and Drug Administration has approved seven medications to help people quit smoking, according to the Centers for Disease Control and Prevention (CDC): five forms of nicotine replacement (the patch, gum, lozenge, inhaler, and nasal spray) and two non-nicotine prescription pills, varenicline and bupropion. A person entering residential treatment in California can ask admissions which of these seven the program can continue, order, or start on site, and whether a combination such as a patch plus gum or lozenges is used, since pairing a long-acting and a short-acting form is a common clinical approach.

A few practical points about these medications in a residential setting:

  • Nicotine replacement can start on day one. Patches and gum do not require a quit date to be set in advance, which makes them the most common option during the first days of a stay.
  • Varenicline and bupropion take time to build. Both are typically started before a planned quit date rather than on it. The prescribing clinician sets the schedule, so this is worth raising early in a stay rather than the week before discharge.
  • Bupropion needs a medical review. It is not appropriate for everyone, including people with a seizure history or those currently withdrawing from alcohol or sedatives. That decision belongs to the medical team.
  • Insurance and cost vary. Coverage for quit medications differs by plan. When you verify your insurance, it is reasonable to ask whether tobacco cessation medications are covered.

Why Nicotine Withdrawal Gets Confused With Everything Else

One of the most useful things we see in the first week is simply naming what is nicotine. People arrive already dealing with withdrawal from alcohol, opioids, stimulants, or sedatives. If their nicotine intake also drops sharply because smoking is limited to set times and places, a second withdrawal stacks on top of the first, and the two are hard to tell apart from the inside.

The overlap is real. Nicotine withdrawal commonly brings these, often within the first few days of cutting down:

  • Irritability: a short fuse that often gets read as “treatment isn’t working” or “I don’t belong here.”
  • Restlessness and poor concentration: the same complaints people have during early alcohol or stimulant withdrawal, which makes groups feel unbearable.
  • Sleep disruption: already common in early recovery, and nicotine changes can make it worse.
  • Cravings that blur together: an urge for a cigarette and an urge for the primary substance can feel like one undifferentiated “I need something.”

The practical consequence is that someone can decide to leave treatment over discomfort that a nicotine patch would have eased. In our experience, asking “When did you last have nicotine, and how much do you usually use in a day?” is one of the most clarifying questions on intake, and it often changes the plan for the first 72 hours.

An important safety note: nicotine withdrawal is uncomfortable but not medically dangerous. Withdrawal from alcohol or benzodiazepines is different and can cause seizures. If you are stopping alcohol or a benzodiazepine, medical supervision is required. Do not reduce or stop those substances on your own before admission without speaking to a medical provider. Our residential treatment program coordinates withdrawal management with medical staff for exactly this reason.

Smoking, Vaping, and House Rules

Policies differ widely between residential programs in California. Some allow smoking in a designated outdoor area at set times. Some are entirely tobacco-free on the property. Many restrict vapes specifically, because cartridges are easy to refill with substances other than nicotine and are hard for staff to check. None of these policies is wrong, but finding out about them on admission day, without a replacement plan, is how people end up miserable in week one.

Families also notice something worth knowing: smoke breaks become social. In programs that allow them, the smoking area is often where people talk most openly. That is not a reason to keep smoking, but it explains why people resist giving it up in the middle of treatment, and why a plan that respects that reality tends to work better than an ultimatum.

What to Do Before Admission Day

Here is a short check you can run this week if you or a family member is preparing for residential treatment.

  1. Write down your actual daily nicotine use. Cigarettes per day, vape pods per day, or pouches per day, plus how soon after waking you use. These numbers are what the medical team uses to choose a replacement dose.
  2. Ask admissions three specific questions: Is the property tobacco-free, or is smoking allowed in a designated area? Are vapes permitted, and if not, what happens to one I bring? Which nicotine replacement products or quit medications can you provide on day one?
  3. Ask whether nicotine is addressed in the treatment plan. You are not committing to quit by asking. You are making sure someone has thought about it.
  4. Do not stockpile. Bringing cartons or extra vapes usually results in them being held at intake. Bring the information instead.

If you want help working through these questions, call our admissions team at (877) 328-1968. We can tell you how nicotine is handled on site and what medication options are available before you commit to a date.

After Discharge: Keeping Nicotine in the Plan

Whatever someone decides about nicotine during a residential stay, the decision should carry into the discharge plan. If a person started nicotine replacement or a prescription quit medication in treatment, the discharge paperwork should say which product, what dose, and who will continue prescribing it. Gaps in that handoff are common, and a person who runs out of patches in the second week home is facing nicotine withdrawal at the same moment they are adjusting to life outside a structured setting.

Free telephone coaching is available nationally through 1-800-QUIT-NOW, which connects callers to their state quitline, as described by the CDC. Adding that number to the discharge plan costs nothing and gives the person a resource that is available beyond office hours.

A Note From Clinical Practice

As a counselor and interventionist, I have watched nicotine decide more admissions than most people would believe. The person who is ready to stop drinking but cannot picture three weeks without a cigarette will sometimes delay treatment over that one fear. A clear, honest answer about nicotine policy and replacement options, given on the first phone call, removes the fear and keeps the focus where it belongs.

If you are weighing residential treatment for yourself or someone you love, reach out at (877) 328-1968. We will walk you through admissions, insurance, and what the first week will look like, including the nicotine question.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Medication decisions, including nicotine replacement and prescription quit medications, should be made with a qualified medical provider. Withdrawal from alcohol or benzodiazepines can be life-threatening and requires medical supervision. If you are in crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline, or call 911 in an emergency.

/by

Starting Buprenorphine in Residential Treatment: The COWS Score, Fentanyl, and What to Ask Admissions

, ,
Nurse reviewing medical records at a computer during an overnight shift in a residential detox unit

Families calling about residential treatment for opioid use often ask one question first: “Will they keep him on his medication?” The second question, usually asked later and with more worry, is “If she isn’t on anything yet, can they start it there?” Those are two different admissions questions, and programs answer them differently. This guide explains how buprenorphine is started in a residential setting, what the COWS score measures, and exactly what to confirm with admissions before the intake date.

Starting Buprenorphine Is a Timed Medical Step, Not a Prescription Handed Over

Buprenorphine is one of the medications for opioid use disorder recognized by the National Institute on Drug Abuse (NIDA) and addressed in the American Society of Addiction Medicine (ASAM) National Practice Guideline. Starting it, a process clinicians call induction or initiation, is timed. Because buprenorphine binds tightly to opioid receptors but activates them only partially, taking the first dose while full-agonist opioids such as fentanyl, heroin or oxycodone are still occupying those receptors can push a person abruptly into withdrawal. That is called precipitated withdrawal, and avoiding it is the main reason the first dose is scheduled around a measured withdrawal score rather than a clock.

In practice, the first day in a residential program that starts buprenorphine on-site looks like this: the person arrives, completes the medical intake, and is then observed. Nursing staff reassess withdrawal on a schedule. When the score shows enough withdrawal, the prescriber approves a first dose, and the person is reassessed again afterward. Many people describe that first wait as the hardest part of week one: restless legs, yawning, gooseflesh, a running nose and the feeling that time has stopped. Knowing in advance that the wait is deliberate makes it easier to get through.

What the COWS Score Measures

The Clinical Opiate Withdrawal Scale (COWS) is an 11-item clinician-rated checklist scored from 0 to 48, used to measure opioid withdrawal before and after a buprenorphine dose. A nurse rates observable signs including resting pulse, sweating, restlessness, pupil size, bone or joint aches, runny nose or tearing, gastrointestinal upset, tremor, yawning, anxiety or irritability, and gooseflesh. The commonly used bands are 5 to 12 for mild withdrawal, 13 to 24 for moderate, 25 to 36 for moderately severe, and above 36 for severe. Each program’s prescriber sets the score at which a first dose is given, so families should ask for that program’s threshold rather than assume one.

The score matters because it turns “I feel terrible” into something a prescriber can act on safely. It also gives the person in treatment something concrete: a number that is moving, which tells them the plan is working.

Why Fentanyl Changed the First Few Days

Clinicians across the field have adjusted induction practices as fentanyl has replaced heroin and pills in much of the street supply. The reasons are worth understanding before admission:

  • Fat-tissue storage: Fentanyl is highly fat-soluble and can be released from body tissue for longer than its short half-life suggests, so withdrawal may build more slowly and unevenly.
  • Unknown supply: Street pills sold as oxycodone or other opioids often contain fentanyl, so the last-use history a person gives may not reflect what they actually took.
  • Precipitated withdrawal risk: Dosing too early is more likely when fentanyl is still active, which is why some prescribers wait for a higher score or use alternative starting approaches.
  • Mixed substances: Fentanyl in the supply is frequently combined with other sedatives, which changes how a medical team monitors the first 24 to 72 hours.

Some prescribers now use lower-dose or “micro-induction” starts for selected patients, where small buprenorphine doses overlap with the existing opioid for several days. Whether a program offers that option, and for whom, is a clinical decision made by its prescriber. It is a fair question to ask.

Safety: Alcohol and Benzodiazepines Change the Plan

Opioid withdrawal is extremely uncomfortable but is rarely life-threatening on its own in otherwise healthy adults. Alcohol and benzodiazepine withdrawal are different: both can cause seizures and other dangerous complications, and both require medical supervision. Anyone who uses alcohol daily or takes benzodiazepines such as alprazolam, clonazepam or lorazepam, prescribed or not, should never stop abruptly, and must tell admissions about that use before the intake date. Combining opioids with alcohol or benzodiazepines also raises overdose risk. If you are worried someone has overdosed, call 911 immediately. For confidential treatment referral, the SAMHSA National Helpline is available 24 hours a day at 1-800-662-4357.

The Operational Truth: Not Every Residential Program Starts Buprenorphine On-Site

From placement work across our network, this is the gap families most often miss. Some residential programs will continue buprenorphine for someone who arrives already on a stable dose but do not start it on-site. Others start it routinely. Some accept people on methadone only if a dosing arrangement with an opioid treatment program can be made in advance, since methadone for opioid use disorder is dispensed through federally certified clinics. A program’s website rarely spells this out. The answer usually lives with the medical director, and the only reliable way to get it is to ask directly.

A related change helps. Since the Consolidated Appropriations Act of 2023 removed the federal “X-waiver” requirement, any clinician with a standard DEA registration that includes Schedule III can prescribe buprenorphine for opioid use disorder. That widened who can prescribe, but it did not make every residential program set up to manage an on-site start. Staffing, nursing coverage overnight and the program’s medical model still decide that.

Five Questions to Ask Admissions Before the Intake Date

Write these down and ask them on the next admissions call. Ask for the answers in writing if you can.

  1. Do you start buprenorphine on-site, or only continue it? If only continue, ask where the person would be inducted first and how the handoff works.
  2. Who is the prescriber, and how often are they available? Ask whether a prescriber can approve a dose overnight or on a weekend.
  3. What COWS score do you use before the first dose, and how often is it rechecked? A clear answer here is a good sign of an organized medical process.
  4. What is your plan for fentanyl exposure? Ask whether lower-dose starts are available and how precipitated withdrawal is managed if it happens.
  5. How does the prescription continue after discharge? Ask who writes the first outpatient prescription and whether a follow-up appointment is booked before the person leaves. A gap of even a few days after discharge is a known risk period.

If you have not yet confirmed coverage, run a benefits check at the same time; our insurance verification page explains what that check tells you. You can also call our team at (877) 328-1968 and we will help you put these questions to the programs you are considering.

What Families Usually Notice in the First Week

Families often expect the person they love to sound better on the first phone call. Sometimes they do. More often, the first call comes on day two or three and sounds flat or irritable, which is consistent with a body adjusting to a new medication and a structured schedule. By the end of the first week, many people report sleeping more normally and thinking less about using. That is the stabilization a residential treatment setting is designed to protect, so that therapy, family sessions and discharge planning can do their work.

Medication is not a shortcut around treatment, and it is not a substitute for one. It is one part of a plan, and it works best when the plan around it is clear before admission day.

Talk With Someone Who Knows the Programs

Bodhi Addiction Treatment & Wellness helps individuals and families in Northern California and beyond find residential programs that match their medical needs, including whether buprenorphine can be started or continued on-site. Learn more about our founder and clinical reviewer, Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i, or call (877) 328-1968 to talk through your options today.

This article is for educational purposes only and is not medical advice. Medication decisions, including whether and when to start buprenorphine, must be made by a licensed prescriber who has evaluated the individual. Do not stop alcohol, benzodiazepines or any prescribed medication without medical supervision. If you or someone you know is in immediate danger, call 911. For a mental health or substance use crisis, call or text 988.

/by

How Long Is Residential Treatment? How Length of Stay Is Set, Concurrent Review, and What to Ask Admissions

, ,
holistic rehab california

“How long will I be there?” is usually the first logistics question on an admissions call, and it is the one with the least satisfying answer. Families want a date so they can plan work leave, childcare and rent. The honest answer is that the length of a residential stay is not fixed on day one. It is set, and reset, by two processes running side by side: the clinical team’s ongoing assessment, and, for people using insurance, the insurer’s periodic reauthorization. Knowing how both work lets you plan for a range instead of being surprised by a single number.

The Short Answer: A Range, Reviewed in Steps

At Bodhi Addiction Treatment, residential programs commonly range from 30 to 90 days, and when a stay is covered by insurance, longer stays are typically reauthorized through concurrent review, often every 7 to 14 days. That means a person admitted to residential treatment in Northern California should not expect one approval for the whole stay; they should expect a series of short reviews, each one asking whether residential care is still the right level, and should plan work leave and family arrangements around the full 30-to-90-day range rather than the first approved block.

Those two figures come from our own residential treatment and insurance verification pages, as published on October 6, 2026. They describe how stays commonly run, not a guarantee for any one person.

Why Length of Stay Matters Clinically

The National Institute on Drug Abuse lists remaining in treatment for an adequate period of time as one of its principles of effective treatment, and notes that the right duration depends on the type and severity of a person’s problems and needs. Leaving early is one of the more common points where recovery plans come apart, which is why the first one to two weeks of a stay get so much attention from staff.

That does not mean longer is always better or that every person needs the maximum. It means the decision to step down should be made on clinical grounds, with a plan in place, rather than on a date picked before anyone knew how the first week would go.

What Actually Decides How Long a Stay Lasts

In practice, length of stay is the product of several factors working together:

  • Withdrawal and medical stability: A stay cannot meaningfully begin its therapy phase until withdrawal is managed, and alcohol or benzodiazepine withdrawal carries seizure risk that requires medical supervision.
  • Dimension-by-dimension assessment: Clinicians reassess the six dimensions in the ASAM Criteria, including relapse risk and the recovery environment, and the level of care follows those ratings.
  • Co-occurring mental health conditions: Depression, anxiety, PTSD or bipolar disorder that surface once substances clear often need time to stabilize before discharge is safe.
  • The home environment: A person returning to a household where others are actively using usually needs a stronger step-down plan, and sometimes more time, than someone returning to a stable, substance-free home.
  • Insurance authorization: The payer approves days in blocks, and each block depends on documentation showing residential care is still medically necessary.

How Concurrent Review Works, Step by Step

Concurrent review is the insurer’s process for approving a stay while it is happening. From the family’s side, it rarely looks like anything, because the conversations happen between the treatment center’s utilization review staff and the insurer’s care manager. Here is the usual sequence:

  1. Initial authorization at admission. The insurer approves an opening block of days based on the intake assessment.
  2. Clinical updates before the block ends. The treatment team sends progress notes, risk ratings and the current treatment plan.
  3. A decision on the next block. The insurer approves more days, approves fewer than requested, or determines that a lower level of care, such as a partial hospitalization program, is now appropriate.
  4. Repeat. This continues, often every 7 to 14 days, until discharge or step-down.

If an insurer stops authorizing residential days before the clinical team believes the person is ready, the center can request a peer-to-peer review between physicians, and the person has appeal rights. A step-down decision from an insurer is not the same as being told treatment is over; it often means the next phase is outpatient-based.

What We See From the Admissions Side

Jonathan Beazley has spent years on admissions and placement calls, and one pattern repeats: families plan around the number they heard first. If someone mentioned “30 days,” the employer gets told 30 days, the leave paperwork says 30 days, and a relative books a flight home for day 31. Then the first concurrent review approves a shorter block than expected, or the clinical team recommends more time, and the plans built around that single number fall over during the most fragile part of the stay.

The less convenient truth is that day 30 is not a clinical milestone. It is a convenient round number. Discharge timing that works tends to come from a written step-down plan, not a calendar.

Three Things to Do Before Admission Day

You can do each of these today, on the phone, before a bed date is set:

  1. Ask admissions this exact question: “How many days does my plan usually approve at admission for residential care, and how often does your team submit concurrent review?” Write down the answer and the name of the person who gave it.
  2. Request leave for the range, not the minimum. If you are using FMLA or California’s CFRA, ask your provider to certify an estimated duration that covers the realistic range. Extending leave mid-stay is possible but adds paperwork at a hard moment.
  3. Ask what the step-down looks like. Ask, “If insurance moves me to a lower level of care, where does that happen and does my therapist stay the same?” Continuity of the clinical relationship often matters more than the exact number of residential days.

If you would like help working through these questions, our admissions team can walk through your specific coverage at (877) 328-1968.

Questions Families Ask About Length of Stay

Can a person leave before the planned discharge? Voluntary residential treatment is voluntary, so yes. Leaving against clinical advice can carry real risk, especially for anyone who used opioids, because tolerance drops during treatment. Anyone leaving early should be offered naloxone and a follow-up appointment.

Does self-pay change the length? Without insurance there is no concurrent review, so length is set by the clinical team and by cost. Ask for the daily rate and a written estimate for the full range before admission.

What if the clinical team wants more time but insurance says no? Ask the center to request a peer-to-peer review, and ask what options exist to continue at the same level while an appeal is pending.

Getting Help

If you are trying to plan around an admission and need a straight answer on timelines and coverage, call (877) 328-1968. For free, confidential treatment referral information at any hour, the SAMHSA National Helpline is available 24 hours a day, 365 days a year. If you or someone you love is in immediate danger, call 911. For a mental health crisis, call or text 988.

This article is for educational purposes only and does not replace individualized medical advice, diagnosis or treatment. Length of stay, insurance authorization and level-of-care decisions vary by person, plan and program. Alcohol and benzodiazepine withdrawal can cause seizures and should never be attempted without medical supervision. Talk with a qualified healthcare provider about your situation.

/by

No Medication for Stimulant Use Disorder: How Residential Treatment Is Planned for Meth and Cocaine, and What to Ask Admissions

, , ,
Clinical setting where sleep after quitting meth is monitored during residential recovery

When a family calls about methamphetamine or cocaine, one of the first questions is usually some version of “What medication will they put him on?” For opioids or alcohol, there is a real answer. For stimulants, there is not, and that single fact changes how a residential stay should be planned, how long it should run, and what has to be in place on discharge day. This post walks through those planning decisions in the order admissions actually works through them.

The Short Answer: No Medication Exists Yet

According to the National Institute on Drug Abuse (NIDA), there is no FDA-approved medication for methamphetamine use disorder or for any other stimulant use disorder, including cocaine. NIDA reports that stimulant withdrawal symptoms typically peak two to three days after last use and may last about a week, while low mood, anxiety and cravings can continue for several months. Because there is no medication to bridge that gap, residential treatment for stimulant use disorder relies on behavioral treatment, with contingency management the best-studied option, alongside cognitive behavioral therapy, group support and motivational interviewing.

That paragraph is the whole planning problem in miniature. The acute phase is short. The vulnerable phase is long. And the tool that carries people through the long phase with opioids, a daily medication, does not exist here yet.

What We See in the First Week

In our admissions work, the stimulant intake that worries families most is often the quiet one. A person who arrived agitated and talking fast is, by day two or three, sleeping most of the day, eating everything on the tray and saying very little. Families on the phone read that as either “he’s fine now” or “something is wrong.” Usually it is neither. It is the crash phase NIDA describes, and it is the point where people most often decide they no longer need to be here, because the chaos that brought them in has gone quiet.

The second pattern is the one that matters for discharge planning: in our experience, a few weeks in, after sleep and appetite settle, cravings tend to return in a different form, cued by a song, a payday, a particular freeway exit. A plan built only around the first week misses this entirely.

Why Stimulant Plans Look Different

These are the mechanisms our clinical team plans around when a stimulant is the primary substance:

  • No medication bridge: without an FDA-approved medication, nothing pharmacological holds cravings down after discharge, so the behavioral plan has to be stronger and start earlier.
  • Short acute phase, long tail: withdrawal peaks within days, but NIDA notes mood and craving symptoms can last months, which is why length of stay should not be set by how someone looks on day seven.
  • Misleading recovery of energy: once sleep normalizes, people often feel better than they have in years, and that feeling is frequently mistaken for being finished with treatment.
  • Cue-driven cravings: stimulant cravings are strongly tied to people, places and routines, so the relapse-prevention plan has to name specific cues rather than general “triggers.”
  • Hidden polysubstance use: many people who use stimulants also use alcohol, benzodiazepines or opioids to come down, and that second substance can carry the greater medical risk.

The Safety Piece Admissions Must Hear

Stimulant withdrawal itself is rarely medically dangerous in the way alcohol withdrawal is, but the substances people use alongside stimulants can be. Alcohol and benzodiazepine withdrawal carry a risk of seizures and require medical supervision. If your loved one drinks heavily or takes Xanax, Klonopin, Valium or similar medications to sleep after using, tell admissions on the first call. That information changes whether medical detox is needed before residential care.

NIDA also notes that methamphetamine, alone or combined with fentanyl, contributes to the overdose crisis. Anyone who uses stimulants from an unregulated supply should have naloxone available, and anyone returning home after reduced use faces changed tolerance.

The crash phase can bring heavy depression. If someone talks about suicide, call or text 988. If there is chest pain, a seizure, severe confusion or psychosis, call 911.

Questions to Ask on the Admissions Call

Here is something you can do today. Before you commit to any program, ask these five questions and write down the answers:

  1. “How do you treat stimulant use disorder specifically?” Listen for named approaches such as contingency management or cognitive behavioral therapy, not just “individual and group therapy.”
  2. “How is length of stay decided?” A good answer references clinical reassessment over time, not a fixed number of days that happens to match an insurance authorization.
  3. “What happens if they want to leave on day three?” Ask what staff actually do, and whether family will be contacted if the person has signed consent.
  4. “Do you screen for alcohol and benzodiazepine use at intake?” The answer should be yes, with a clear path to medical detox if needed.
  5. “What does the step-down plan look like?” Ask whether they arrange outpatient treatment or intensive outpatient care before discharge, with a first appointment date already set.

If you want to talk through these with someone before calling anywhere else, our team is available at (877) 328-1968.

How Length of Stay Gets Decided

For stimulant use disorder, length of stay in residential treatment is driven by clinical criteria, typically the ASAM dimensions, rather than by withdrawal severity, because withdrawal is usually over within the first week. What clinicians are actually watching after that is relapse risk, the home environment and whether the person can name and manage their own cues.

Insurance authorizations are often issued in short blocks and reviewed. That is normal. What families should know is that a utilization review asking “why is this person still here if withdrawal is over?” is answered with documentation about relapse risk and recovery environment, not withdrawal. If you are unsure what your plan covers, you can verify insurance benefits before admission so there are no surprises at the first review.

Contingency Management: What It Is and How to Ask

Contingency management offers small, tangible incentives, such as vouchers or gift cards, for verified progress such as negative drug tests or attendance. NIDA describes it as the best-studied behavioral treatment for methamphetamine use disorder and the one most associated with treatment success. It can feel counterintuitive to families. It works in part because stimulants hijack the brain’s reward system, and small, immediate, predictable rewards help rebuild that system around something other than the drug.

Availability varies by program and payer. Ask directly whether it is offered during residential care, after discharge, or through a referral, and who pays for the incentives.

Discharge Without a Prescription

When someone leaves residential treatment for opioid use disorder, a medication often travels with them. With stimulants, the discharge plan has to carry that weight instead. Before discharge day, confirm in writing:

  • The date and time of the first outpatient or IOP appointment
  • A named list of personal cues and the plan for each
  • Whether mental health follow-up is scheduled for mood symptoms that may persist
  • Where naloxone is kept at home
  • Who the person will call in the first 72 hours if cravings spike

SAMHSA’s National Helpline, 1-800-662-HELP (4357), is a free, confidential, 24/7, 365-day-a-year referral service in English and Spanish, and it is a useful backup number to keep on the fridge.

A Note From the Clinical Side

The families who do best with stimulant treatment are usually not the ones who found the perfect program. They are the ones who stopped measuring progress by how their loved one looked in week one and started asking what the plan was for week eight. That shift alone changes the conversation with any treatment team. Learn more about Jonathan Beazley and the clinical approach at Bodhi.

If someone you love is using methamphetamine or cocaine and you are trying to figure out next steps, call us at (877) 328-1968. We can help you sort out level of care, insurance and timing, even if Bodhi turns out not to be the right fit.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Alcohol and benzodiazepine withdrawal can cause seizures and require medical supervision. If you or someone you know is in crisis, call or text 988, or call 911 in an emergency.

/by

Alcohol Detox Before Residential Treatment: What the CIWA-Ar Score Measures and What to Tell Admissions

, ,
clinician monitoring a patient vital signs monitor during medically supervised detox

When someone calls about alcohol detox, the first clinical questions are rarely about motivation. They are about timing, quantity, and history: when was the last drink, how much has been typical each day, and has withdrawal ever caused a seizure or confusion before. Those answers shape how withdrawal is monitored, and the tool most programs use to track it is a short scored checklist called the CIWA-Ar. This guide explains what that score is, how it is used during the first days of care, and what you can prepare before calling admissions.

Safety first: alcohol withdrawal can cause seizures and delirium tremens, both of which can be life-threatening. Stopping heavy, daily drinking should happen under medical supervision, not alone at home. If someone is having a seizure, is severely confused, or is seeing or hearing things that are not there, call 911.

What the CIWA-Ar Is

The Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar), is a 10-item scale that nurses and clinicians use to measure the severity of alcohol withdrawal, with a maximum possible score of 67. It rates nausea and vomiting, tremor, sweating, anxiety, agitation, headache, three kinds of perceptual disturbance (touch, hearing, and vision), and orientation. A higher score means more severe withdrawal, and the score is repeated at set intervals so the care team can see whether symptoms are rising or settling rather than relying on a single impression.

The American Society of Addiction Medicine (ASAM) describes the CIWA-Ar as one of the validated tools for assessing withdrawal severity in its clinical guidelines on alcohol withdrawal management. Broadly, lower scores suggest mild withdrawal, scores in the teens suggest moderate withdrawal, and higher scores indicate severe withdrawal that calls for closer medical care. Exact cutoffs and responses vary by protocol and by the prescriber’s judgment.

The Timeline the Score Is Tracking

The score matters because alcohol withdrawal is not static. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) and ASAM both describe a general pattern, though individual courses vary:

  • Roughly 6 to 24 hours after the last drink: early symptoms such as tremor, sweating, anxiety, nausea, and poor sleep often begin.
  • Roughly 12 to 48 hours: the window when withdrawal seizures most commonly occur.
  • Roughly 48 to 96 hours: the period when delirium tremens, the most dangerous form of withdrawal, typically appears in the people who develop it.

This is why the time of the last drink is the single most useful fact a family can give an admissions team. Someone who arrives eight hours after their last drink with a low score may still be climbing. Someone who arrives four days out with a low score is in a very different place. The number on the sheet only means something alongside the clock.

Why Withdrawal Can Escalate

Several factors make withdrawal more likely to become severe, and a good intake process asks about each one:

  • Prior complicated withdrawal: a history of withdrawal seizures or delirium tremens is one of the strongest warning signs that the next withdrawal could be serious.
  • Heavy, daily, long-term drinking: the brain adapts to steady alcohol exposure, and removing it suddenly leaves the nervous system overexcited.
  • Repeated cycles of detox and relapse: clinicians often see withdrawal grow harder with each episode, a pattern sometimes called kindling.
  • Other sedatives in the picture: benzodiazepines or sleep medications taken alongside alcohol complicate withdrawal, and stopping them abruptly also carries seizure risk.
  • Medical conditions: liver disease, electrolyte problems, poor nutrition, and recent illness can all make withdrawal harder to manage safely.

How the Score Is Used Day to Day

In a medically monitored setting, the CIWA-Ar is usually taken at admission and then repeated on a schedule, often every few hours in the first days and more often when scores are climbing. Vital signs such as heart rate, blood pressure, and temperature are checked alongside it. Many protocols use the score to guide when withdrawal medication is given, an approach often called symptom-triggered dosing. Others use a fixed schedule that tapers down over several days. Both approaches are described in clinical guidance, and the prescriber chooses based on the person’s history and risk.

Families sometimes worry when they hear that a loved one “scored a 12.” A single number is not a verdict. What clinicians watch is the direction: a score that drops over successive checks usually means medication and support are working. A score that keeps rising, or new confusion or hallucinations, means the level of care may need to change, including transfer to a hospital.

The CIWA-Ar also has limits. It depends partly on what the person reports, so someone who downplays symptoms, or who is too sick to describe them, may score lower than their condition warrants. That is one reason vital signs and direct observation are used alongside it.

What This Looks Like in Real Admissions

From years of working in residential admissions in Northern California, one pattern stands out: the information that changes the plan most often is information people did not think to mention. A person reports “a few beers a night” and a family member later clarifies it was a fifth of vodka. Someone forgets to say they had a seizure during a previous attempt to quit. Someone else has a prescription for a benzodiazepine they did not consider relevant. None of this is unusual, and nobody is in trouble for it. But each of these details can move a person from a lower level of monitoring to a higher one, and it is far safer to know before arrival than to learn it at hour 30.

Another common situation is the “last night out” before admission. People sometimes drink heavily the night before they come in, reasoning that it will be the last time. That pushes the riskiest withdrawal hours into the first day or two of care, which a medically monitored program, such as an alcohol detox setting near Santa Cruz, can handle, but only if the team knows the timing accurately.

What to Prepare Before You Call Admissions

You can do this today, in about ten minutes. Write down the following on one page or in a note on your phone, and have it ready when you call (877) 328-1968:

  1. Last drink: the date and approximate time, and what it was.
  2. Typical daily amount: the type of alcohol and a realistic quantity, such as “one 750 ml bottle of wine per day,” not a rough guess like “a lot.”
  3. How long at that level: weeks, months, or years of daily drinking.
  4. Withdrawal history: any past seizures, delirium tremens, hallucinations, or hospital stays when stopping.
  5. All current medications: including any benzodiazepines, sleep aids, opioids, and over-the-counter products.
  6. Medical conditions: especially liver, heart, or seizure disorders, and any recent illness.

Then ask the admissions team one direct question: “Based on this history, will withdrawal be medically monitored on site, or will detox happen somewhere else first?” The answer tells you whether the program’s level of care matches the risk. Our page on residential treatment explains how care continues once withdrawal has stabilized, and you can verify insurance benefits before admission so coverage questions do not delay a safe start.

After Withdrawal Stabilizes

Withdrawal management is the beginning of treatment, not the whole of it. The Substance Abuse and Mental Health Services Administration (SAMHSA) emphasizes that ongoing treatment and support are what help people sustain recovery after the acute phase. Once scores have settled, the focus shifts to therapy, relapse prevention planning, family involvement, and, where appropriate, medications for alcohol use disorder. The National Institute on Alcohol Abuse and Alcoholism offers family-friendly material on treatment options that can help you prepare questions.

If you are trying to decide whether a loved one needs medically supervised detox before residential care, talk it through with a clinician rather than guessing. Call (877) 328-1968 to speak with our admissions team. If someone is in immediate danger, call 911. For emotional crisis support, call or text 988.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Alcohol withdrawal can be life-threatening; do not stop heavy drinking without medical supervision. Always consult a qualified healthcare provider about your specific situation.

/by

Sober Living After Residential Treatment in California: What Is Licensed, What Isn’t, and What to Check Before Move-In

, , , ,
Clinician reviewing the cocaine withdrawal timeline with a client in residential detox

For many people finishing residential treatment, the hardest question is not whether to keep going in recovery. It is where to sleep on the night of discharge. Going straight back to the same apartment, the same roommates, and the same routines is a real risk, and sober living is often the answer families reach for. But “sober living” covers a wide range of homes in California, from carefully run residences with house managers and written standards to a rented house with a list of rules taped to the fridge. This guide explains how sober living is regulated here, what the support levels mean, and the specific things to confirm before anyone signs a lease or pays a deposit.

What Sober Living Is, and What It Is Not

In California, a sober living home that provides no treatment services generally does not need a license from the Department of Health Care Services (DHCS), the state agency that licenses residential addiction treatment facilities. That means the protections that come with a licensed residential treatment program, such as required staffing, clinical oversight, and state inspection, do not automatically apply to a sober living home. Families can check quality through voluntary standards instead: the National Alliance for Recovery Residences (NARR) defines four levels of recovery residence support, from Level I (peer-run, no paid staff) to Level IV (a clinical setting that is usually a licensed program). Asking which level a home operates at, and whether it is certified by a NARR affiliate, is the fastest way to know what a given house actually offers.

Sober living is housing with structure. It is not treatment. A good home expects residents to be engaged in treatment somewhere else, usually an outpatient or intensive outpatient program, plus mutual-support meetings, work, or school. If a home describes itself as providing therapy, medication management, or detox without a DHCS license, that is a question worth asking directly.

Why the Weeks After Residential Treatment Carry Extra Risk

The National Institute on Drug Abuse describes addiction as a chronic condition and notes that remaining in treatment for an adequate period is important to good outcomes (see NIDA’s Principles of Drug Addiction Treatment). The step down from 24-hour care is where that continuity is easiest to lose. Several things change on the same day:

  • Structure drops away: a residential schedule fills nearly every hour, and discharge can leave whole afternoons empty.
  • Tolerance is lower: after a period without opioids, a return to a previous dose can cause an overdose, which is why naloxone should go home with anyone who has used opioids.
  • Old cues return: the same streets, contacts, and stressors that were present before treatment are there waiting.
  • Accountability thins out: no one is checking in at breakfast, and early warning signs can go unnoticed for days.

A sober living home is one way to keep some of that structure in place while a person rebuilds work, relationships, and outpatient care.

What We See in Placement Work

At Bodhi, our work is matching people with treatment programs and the housing that follows them. A few patterns come up again and again, and none of them appear on a home’s website.

Medication policies vary more than families expect. Some homes do not accept residents who take buprenorphine, methadone, or certain psychiatric medications, even when those medications were prescribed during treatment. Medications for opioid use disorder are an evidence-based standard of care, and a person should not have to choose between their prescription and their housing. We confirm the policy in writing before a referral, every time.

The bed is often the bottleneck, not the money. Well-run homes near the Bay Area and Santa Cruz County can have waiting lists. When discharge is set but housing is not, people end up going “home for a few days” that turn into weeks. The housing search should start in the second or third week of a residential stay, not the last day.

“Zero tolerance” means different things. In some homes a single positive test means immediate eviction with nowhere to go that night. In others, a return to use triggers a meeting, a safety plan, and a referral back to a higher level of care. Families should know which kind of house they are choosing before anything goes wrong.

Seven Questions to Ask Before Move-In

Bring this list to the tour or the phone call. Ask the house manager to answer in writing, by email or text, so there is a record.

  1. What NARR level do you operate at, and are you certified by a NARR affiliate? Ask for the certifying organization and the date the certification was last renewed.
  2. What is your policy on prescribed medications, including buprenorphine, methadone, naltrexone, and psychiatric medications? How are they stored?
  3. What happens after a return to use? Is there a written relapse policy, and where does the resident go if they must leave?
  4. How often is drug and alcohol testing done, and who pays for it?
  5. What are the total move-in costs? Ask for the deposit, the first payment, weekly or monthly rent, and any program fees as separate line items.
  6. Is there an on-site house manager, and what hours are they present?
  7. What outside participation is required? Outpatient treatment, meetings, employment, curfew, and visitor rules should all be spelled out.

If a home cannot or will not answer these questions, that is useful information too. You can also call our team at (877) 328-1968 and we will walk through the answers with you.

Safety Rules That Apply Whatever the Housing

Sober living homes are not medical settings. If someone returns to heavy drinking or to regular benzodiazepine use and then stops suddenly, withdrawal can cause seizures and can be life-threatening. That person needs medically supervised withdrawal management, not a night of rest at the house. The same is true for anyone showing confusion, hallucinations, a high fever, or severe agitation after stopping a substance. Call 911 in an emergency.

Anyone who has used opioids should keep naloxone in their room and make sure housemates know where it is. Families can find treatment and support options through the SAMHSA National Helpline, which is free, confidential, and available 24 hours a day at 1-800-662-4357. If someone is in emotional crisis or thinking about suicide, call or text 988.

How Sober Living Fits the Discharge Plan

Sober living works best as one piece of a written continuing care plan, not a standalone solution. The American Society of Addiction Medicine’s ASAM Criteria describe care as a continuum, with people moving between levels of intensity as their needs change. In practice, a solid plan names all of the following before discharge day:

  • The sober living address and move-in date
  • The outpatient or intensive outpatient program, with a first appointment date already booked
  • The prescriber who will continue any medications, and the date of the first refill
  • A primary support person, and what they should do if they notice warning signs
  • A clear “if things go wrong” step, such as who to call to return to a higher level of care

One thing you can do today: if a loved one is currently in residential treatment, ask their case manager at the next family call, “Which sober living homes are you considering, and what is each one’s medication and relapse policy?” If the answer is that housing has not been discussed yet, ask to put it on the agenda this week.

Getting Help Choosing the Right Next Step

Choosing housing after treatment can feel like one more decision on top of a dozen others. You do not have to sort through it alone. Our treatment consultants help Northern California families compare residential programs, outpatient options, and recovery residences, and we check the details that matter before a referral is made. Call (877) 328-1968 to talk through your situation.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Sober living policies and California regulations can change, so confirm current details directly with the home and the relevant agency. If you or someone you love is in immediate danger, call 911. For a mental health crisis, call or text 988.

/by